Aramchol news dated 09/17/2024

The latest news on Aramchol, as of September 17, 2024, is that Galmed Pharmaceuticals has announced the grant of a new patent for the combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the treatment of NASH and liver fibrosis. This patent extends the patent protection of Aramchol until September 2039, providing legal and regulatory support for the drug's development and potential market entry. The patent news, combined with the positive clinical trial results for Aramchol in NASH, could be contributing to the surge in Galmed Pharmaceuticals' stock price on September 17, 2024.